These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 11729107

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The risk of esophageal adenocarcinoma after antireflux surgery.
    Lagergren J, Ye W, Lagergren P, Lu Y.
    Gastroenterology; 2010 Apr; 138(4):1297-301. PubMed ID: 20080091
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
    Wu AH, Tseng CC, Bernstein L.
    Cancer; 2003 Sep 01; 98(5):940-8. PubMed ID: 12942560
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?
    Lagergren J, Viklund P.
    World J Surg; 2007 Mar 01; 31(3):465-9. PubMed ID: 17171490
    [Abstract] [Full Text] [Related]

  • 10. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1998 Sep 01; 7(9):749-56. PubMed ID: 9752982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia.
    Terry P, Lagergren J, Wolk A, Nyrén O.
    Nutr Cancer; 2000 Sep 01; 38(2):186-91. PubMed ID: 11525596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
    Lagergren J, Bergström R, Adami HO, Nyrén O.
    Ann Intern Med; 2000 Aug 01; 133(3):165-75. PubMed ID: 10906830
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
    Kauttu TM, Rantanen TK, Sihvo EI, Räsänen JV, Puolakkainen P, Salo JA.
    Eur J Cardiothorac Surg; 2011 Dec 01; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
    Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, Rascoe PA.
    Dis Esophagus; 2016 Oct 01; 29(7):747-751. PubMed ID: 26455587
    [Abstract] [Full Text] [Related]

  • 20. [Malign complication of gastroesophageal reflux: adenocarcinoma of esophagus and gastric cardia].
    Sihvo E, Salo J.
    Duodecim; 2000 Oct 01; 116(17):1907-11. PubMed ID: 12001647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.